These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38777674)

  • 1. A Novel EGFR Germline Mutation in Lung Adenocarcinoma: Case Report and Literature Review.
    Sharma P; Mahadevia H; Donepudi S; Kujtan L; Gustafson B; Ponvilawan B; Al-Obaidi A; Subramanian J; Bansal D
    Clin Lung Cancer; 2024 Jul; 25(5):479-482. PubMed ID: 38777674
    [No Abstract]   [Full Text] [Related]  

  • 2. A Case of Novel Inversion Mutation of EGFR Exon 19 Leading to Primary Resistance to EGFR TKIs in Lung Adenocarcinoma.
    Li S; Zhao J; Wang Q
    J Thorac Oncol; 2018 Jun; 13(6):e97-e101. PubMed ID: 29501421
    [No Abstract]   [Full Text] [Related]  

  • 3. EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer.
    Lu S; Yu Y; Li Z; Yu R; Wu X; Bao H; Ding Y; Shao YW; Jian H
    J Thorac Oncol; 2019 Apr; 14(4):732-736. PubMed ID: 30610926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Adenocarcinoma Associated With Germline
    Sovich JL; Dan T; Gemmell A; Clark C; Gagan J; Dowell JE
    JCO Precis Oncol; 2022 Jul; 6():e2100559. PubMed ID: 35862867
    [No Abstract]   [Full Text] [Related]  

  • 5. A Case of Adenocarcinoma of the Lung With EGFR T790 Mutation Presenting With Chylous Ascites.
    Nakashima K; Hara Y; Sato T; Shinkai M; Kaneko T
    J Thorac Oncol; 2018 Aug; 13(8):1227-1228. PubMed ID: 29631036
    [No Abstract]   [Full Text] [Related]  

  • 6. Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients With Lung Adenocarcinoma.
    Lou Y; Pecot CV; Tran HT; DeVito VJ; Tang XM; Heymach JV; Luthra R; Wistuba II; Zuo Z; Tsao AS
    Clin Lung Cancer; 2016 Mar; 17(2):e5-11. PubMed ID: 26700910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid metastasis of pulmonary adenocarcinoma with EGFR G719A mutation: Genetic confirmation with liquid-based cytology specimens.
    Yamada Y; Shirahase H; Fukiya M; Yoshizawa A; Minamiguchi S; Ozasa H; Haga H
    Cytopathology; 2021 May; 32(3):364-366. PubMed ID: 33184941
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of "Lung Cancer Management in Indian context".
    Nakra T; Mehta A; Bal A; Nambirajan A; Mishra D; Midha D; Gupta N; Arora N; Gupta P; Gupta P; Singh V; Jain D
    Curr Probl Cancer; 2020 Jun; 44(3):100561. PubMed ID: 32169258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma.
    Chang LC; Chen KY; Shih JY; Yu CJ; Hsieh MS
    J Thorac Oncol; 2017 Jul; 12(7):e94-e95. PubMed ID: 28629547
    [No Abstract]   [Full Text] [Related]  

  • 10. Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma.
    Centeno I; Blay P; Santamaría I; Astudillo A; Pitiot AS; Osorio FG; González-Arriaga P; Iglesias F; Menéndez P; Tardón A; Freije JM; Balbín M
    BMC Cancer; 2011 May; 11():172. PubMed ID: 21575252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid-based cytology specimens for next-generation sequencing in lung adenocarcinoma: challenges and evaluation of targeted therapy.
    Xiao X; Sun Z; Liang S; Li W; Guo H; Zhao H; Zhao L; Ma H; Sun Y; Wang C; Chang X; Zhang Z
    BMC Cancer; 2024 Jun; 24(1):749. PubMed ID: 38902688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing assisted diagnosis of cervical metastasis in EGFR-mutated lung adenocarcinoma: A case report.
    Xu L; Li K; Chen X; Chen B; Li J; Wu L
    Thorac Cancer; 2021 Oct; 12(19):2622-2627. PubMed ID: 34505336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR Mutations.
    Petrini I; Bruno R; Di Stefano I; Aprile V; Korasidis S; Pardini E; Chella A; Alì G
    Clin Lung Cancer; 2024 Jul; 25(5):e238-e242. PubMed ID: 38729783
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of T790M mutation among TKI-therapy resistant Lebanese lung cancer patients based on liquid biopsy analysis: a first report from a major tertiary care center.
    Assi H; Tfayli A; Assaf N; Daya SA; Bidikian AH; Kawsarani D; Fermanian P; Zaatari G; Mahfouz R
    Mol Biol Rep; 2019 Aug; 46(4):3671-3676. PubMed ID: 31147859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoid Adenocarcinoma of the Lung with EGFR Mutation and the Response to Tyrosine Kinase Inhibitors.
    Chen HF; Wang WX; Li XL; Xu CW; Du KQ; Zhu YC; Fang MY
    J Thorac Oncol; 2019 Oct; 14(10):e217-e219. PubMed ID: 31558230
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of a Novel MET Exon 14 Skipping Variant Coexistent with EGFR Mutation in Lung Adenocarcinoma Sensitive to Combined Treatment with Afatinib and Crizotinib.
    Zeng L; Xia C; Zhang Y; Yang N
    J Thorac Oncol; 2019 Apr; 14(4):e70-e72. PubMed ID: 30922580
    [No Abstract]   [Full Text] [Related]  

  • 17. EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature.
    Ricordel C; Labalette-Tiercin M; Lespagnol A; Kerjouan M; Dugast C; Mosser J; Desrues B; Léna H
    Lung Cancer; 2015 Jan; 87(1):80-4. PubMed ID: 25433984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline EGFR T790M mutation found in multiple members of a familial cohort.
    Yu HA; Arcila ME; Harlan Fleischut M; Stadler Z; Ladanyi M; Berger MF; Robson M; Riely GJ
    J Thorac Oncol; 2014 Apr; 9(4):554-8. PubMed ID: 24736080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
    Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major Clinical Response to Afatinib Monotherapy in Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion Mutation.
    Urbán L; Dóczi R; Vodicska B; Tihanyi D; Horváth M; Kormos D; Takács I; Pápai-Székely Z; Póka-Farkas Z; Várkondi E; Schwáb R; Hegedüs C; Vályi-Nagy I; Peták I
    Clin Lung Cancer; 2021 Jan; 22(1):e112-e115. PubMed ID: 33082101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.